Oppenheimer Asset Management’s Sage Therapeutics SAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,568	Closed	-$113K	–	1617
2019 Q4	$113K	Sell	1,568 -2,929	-65%	-$360K	﹤0.01%	1170
2019 Q3	$631K	Sell	4,497 -225	-5%	-$37.6K	0.01%	746
2019 Q2	$865K	Sell	4,722 -143	-3%	-$24.4K	0.02%	662
2019 Q1	$774K	Buy	4,865 +874	+22%	+$127K	0.02%	678
2018 Q4	$382K	Sell	3,991 -328	-8%	-$37.5K	0.01%	837
2018 Q3	$610K	Buy	4,319 +377	+10%	+$58.2K	0.01%	756
2018 Q2	$617K	Buy	3,942 +1,860	+89%	+$292K	0.02%	733
2018 Q1	$335K	Buy	+2,082	New	+$353K	0.01%	902
2017 Q4	–	Sell	-1,944	Closed	-$122K	–	1407
2017 Q3	$122K	Buy	1,944 +1,565	+413%	+$123K	﹤0.01%	1151
2017 Q2	$30K	Sell	379 -4	-1%	-$289	﹤0.01%	1442
2017 Q1	$27K	Buy	+383	New	+$22.4K	﹤0.01%	1441